- Home
- VRDN vs RLX Comparison
VRDN vs RLX Comparison
Compare VRDN & RLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRDN | RLX |
|---|---|---|
| Founded | 2006 | 2018 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.9B |
| IPO Year | 2014 | 2020 |
Fundamental Metrics
Financial Performance| Metric | VRDN | RLX |
|---|---|---|
| Price | $18.82 | $2.19 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 13 | 1 |
| Target Price | ★ $38.25 | $2.50 |
| AVG Volume (30 Days) | 1.8M | ★ 2.5M |
| Earning Date | 05-05-2026 | 05-15-2026 |
| Dividend Yield | N/A | ★ 5.02% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $5,706,000.00 | N/A |
| Revenue This Year | $27.65 | $48.73 |
| Revenue Next Year | $253.29 | $14.96 |
| P/E Ratio | ★ N/A | $28.09 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $9.90 | $1.66 |
| 52 Week High | $34.29 | $2.68 |
Technical Indicators
Market Signals| Indicator | VRDN | RLX |
|---|---|---|
| Relative Strength Index (RSI) | 23.68 | 44.61 |
| Support Level | $17.91 | $2.09 |
| Resistance Level | $19.42 | $2.42 |
| Average True Range (ATR) | 1.12 | 0.09 |
| MACD | -1.02 | 0.00 |
| Stochastic Oscillator | 13.93 | 34.33 |
Price Performance
Historical ComparisonAbout VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).
About RLX RLX Technology Inc. each representing the right to receive one (1) ordinary share
RLX Technology Inc is engaged in the manufacturing of e-vapor products for adult smokers. It has an integrated offline distribution and "Branded store plus" retail model tailored to China's e-vapor market.